Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation

Abstract

Limited data exist regarding the incidence and factors associated with outcome of invasive Pseudomonal infections in hematopoietic cell transplant (HCT). A retrospective analysis of cases of invasive Pseudomonas aeruginosa infection and factors associated with outcome was performed. P. aeruginosa invasive infection occurred in 95 of 5772 patients (1.65%) a median of 63 days after HCT (range 5–1435). Only 28% of infections occurred during periods of neutropenia (absolute neutrophil count<500 cells/mm3). Infection-attributable mortality during the initial episode of infection was 35.8%. Factors associated with initial mortality included the presence of a copathogen and high-dose steroid use. Ten (16.4%) of those who survived the initial infection experienced a recurrence of P. aeruginosa infection at a median of 9 days (range 3–17) after stopping antibiotics and 60% of those died as a result of recurrent infection a median of 1 day (range 1–7) after onset of recurrence. Grade 3–4 graft-versus-host disease was associated with a higher risk of recurrent infection. The risk of recurrence was not influenced by the presence of copathogens. Thus, invasive P. aeruginosa infections are associated with high recurrence rates and mortality in this immunocompromised population. Aggressive attempts to reduce immunosuppression and to treat copathogens may help during the initial infection.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M . High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis 2002; 185: 273–282.

    Article  Google Scholar 

  2. Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97: 3380–3389.

    Article  CAS  Google Scholar 

  3. Williamson EC, Millar MR, Steward CG, Cornish JM, Foot AB, Oakhill A et al. Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol 1999; 104: 560–568.

    Article  CAS  Google Scholar 

  4. Lossos IS, Breuer R, Or R, Strauss N, Elishoov H, Naparstek E et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 1995; 60: 672–678.

    Article  CAS  Google Scholar 

  5. Walter EA, Bowden RA . Infection in the bone marrow transplant recipient. Infect Dis Clin North Am 1995; 9: 823–847.

    CAS  PubMed  Google Scholar 

  6. Yuen KY, Woo PC, Hui CH, Luk WK, Chen FE, Lie AK et al. Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment. Bone Marrow Transplant 1998; 21: 1137–1143.

    Article  CAS  Google Scholar 

  7. Sayer HG, Longton G, Bowden R, Pepe M, Storb R . Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention. Blood 1994; 84: 1328–1332.

    CAS  PubMed  Google Scholar 

  8. Parkkali T, Ruutu T, Stenvik M, Kuronen T, Kayhty H, Hovi T et al. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. Apmis 1996; 104: 383–388.

    Article  CAS  Google Scholar 

  9. Bodey GP, Buckley M, Sathe YS, Freireich EJ . Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–340.

    Article  CAS  Google Scholar 

  10. Schimpff SC, Young VM, Greene WH, Vermeulen GD, Moody MR, Wiernik PH . Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med 1972; 77: 707–714.

    Article  CAS  Google Scholar 

  11. Anonymous. Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. JAMA 1994; 272: 1183–1189.

    Article  Google Scholar 

  12. Karp JE, Merz WG, Hendricksen C, Laughon B, Redden T, Bamberger BJ et al. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1987; 106: 1–7.

    Article  CAS  Google Scholar 

  13. Lew MA, Kehoe K, Ritz J, Antman KH, Nadler L, Kalish LA et al. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. J Clin Oncol 1995; 13: 239–250.

    Article  CAS  Google Scholar 

  14. Petersen F, Thornquist M, Buckner C, Counts G, Nelson N, Meyers J et al. The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study. Infection 1988; 16: 199–208.

    Article  CAS  Google Scholar 

  15. Collin BA, Leather HL, Wingard JR, Ramphal R . Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001; 33: 947–953.

    Article  CAS  Google Scholar 

  16. Pollack M . Pseudomonas aeruginosa and related bacteria. In: Blacklow NR (ed). Infectious Diseases, 2nd edn. WB Saunders: New York, 1998.

    Google Scholar 

  17. Wendt C, Messer SA, Hollis RJ, Pfaller MA, Wenzel RP, Herwaldt LA . Recurrent gram-negative bacteremia: incidence and clinical patterns. Clin Infect Dis 1999; 28: 611–617.

    Article  CAS  Google Scholar 

  18. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730–751.

    Article  Google Scholar 

  19. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG, Levine AS, Deisseroth AB et al. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med 1979; 67: 194–200.

    Article  CAS  Google Scholar 

  20. Pfaller MA, Hollis RJ, Sader HS . PFGE of chromosomal restriction fragments. In: Isenberg HD (ed). Clinical Microbiology Procedures Handbook, Suppl 1. American Society for Microbiology: Washington DC, 1992, pp 10.5.c.1–10.5.c.11.

    Google Scholar 

  21. Wendt C, Messer SA, Hollis RJ, Pfaller MA, Wenzel RP, Herwaldt LA . Molecular epidemiology of gram-negative bacteremia. Clin Infect Dis 1999; 28: 605–610.

    Article  CAS  Google Scholar 

  22. Mitchell AE, Derrington P, Turner P, Hunt LP, Oakhill A, Marks DI . Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome. Bone Marrow Transplant 2004; 33: 303–310.

    Article  CAS  Google Scholar 

  23. Capdevila JA, Almirante B, Pahissa A, Planes AM, Ribera E, Martinez-Vazquez JM . Incidence and risk factors of recurrent episodes of bacteremia in adults. Arch Intern Med 1994; 154: 411–415.

    Article  CAS  Google Scholar 

  24. Junghanss C, Marr KA, Carter RA, Sandmaier BM, Maris MB, Maloney DG et al. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant 2002; 8: 512–520.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported NIH 18029 (MB), NIH 15704 (MB), The Joel Meyers Endowment Fund of the FHCRC (MH). We thank Rachel A Carter and Gary Schoch of the FHCRC for assistance with statistical analyses and database services, Bruce Ulness of the University of Washington microbiology laboratory for bacterial sensitivities, and the Department of Laboratory Medicine at the University of Washington for performing the PFGE analyses.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Boeckh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hakki, M., Limaye, A., Kim, H. et al. Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation. Bone Marrow Transplant 39, 687–693 (2007). https://doi.org/10.1038/sj.bmt.1705653

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705653

Keywords

This article is cited by

Search

Quick links